SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-033362
Filing Date
2021-05-17
Accepted
2021-05-17 21:57:01
Documents
1
Period of Report
2021-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7801
  Complete submission text file 0001209191-21-033362.txt   9517
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PROTEOSTASIS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 500 BOSTON MA 02135
Business Address
Chowdhury Badrul A. (Reporting) CIK: 0001776662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 21933587